Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · IEX Real-Time Price · USD
11.31
+0.79 (7.51%)
At close: May 24, 2024, 4:00 PM
11.87
+0.56 (4.95%)
After-hours: May 24, 2024, 4:55 PM EDT

Boundless Bio Statistics

Total Valuation

Boundless Bio has a market cap or net worth of $251.70 million. The enterprise value is $147.78 million.

Market Cap 251.70M
Enterprise Value 147.78M

Important Dates

The last earnings date was Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

Boundless Bio has 22.25 million shares outstanding.

Shares Outstanding 22.25M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 10.80%
Owned by Institutions (%) 39.78%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.54

Current Ratio 10.54
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$738,125
Employee Count 72
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 54.61
Average Volume (30 Days) 193,450

Short Selling Information

The latest short interest is 848,909, so 3.81% of the outstanding shares have been sold short.

Short Interest 848,909
Short Previous Month 849,413
Short % of Shares Out 3.81%
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Pretax Income n/a
Net Income -53.15M
EBITDA n/a
EBIT n/a
Earnings Per Share (EPS) -$2.39
Full Income Statement

Balance Sheet

The company has $105.44 million in cash and $1.52 million in debt, giving a net cash position of $103.92 million or $4.67 per share.

Cash & Cash Equivalents 105.44M
Total Debt 1.52M
Net Cash 103.92M
Net Cash Per Share $4.67
Equity / Book Value -141.18M
Book Value Per Share -6.34
Working Capital 101.52M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Boundless Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -21.11%
FCF Yield n/a

Analyst Forecast

The average price target for Boundless Bio is $23.00, which is 103.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target $23.00
Price Target Difference 103.36%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a